Article Details

Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 - GlobeNewswire

Retrieved on: 2022-06-26 01:00:41

Tags for this article:

Click the tags to see associated articles and topics

Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 - GlobeNewswire. View article details on hiswai:

Excerpt

Late-Breaking Oral Presentation: “Primary data analyses of MAESTRO-NAFLD-1, a 52 week double-blind placebo-controlled phase 3 clinical trial of ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up